Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.

MLA

Bird, Steven T., et al. “Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride.” The Journal of Urology, vol. 190, no. 5, Nov. 2013, pp. 1811–14. EBSCOhost, https://doi.org/10.1016/j.juro.2013.04.132.

APA

Bird, S. T., Brophy, J. M., Hartzema, A. G., Delaney, J. A. C., & Etminan, M. (2013). Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride. The Journal of Urology, 190(5), 1811–1814. https://doi.org/10.1016/j.juro.2013.04.132

Chicago

Bird, Steven T, James M Brophy, Abraham G Hartzema, Joseph A C Delaney, and Mahyar Etminan. 2013. “Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride.” The Journal of Urology 190 (5): 1811–14. doi:10.1016/j.juro.2013.04.132.